HomeAI · summaries
Storia in 15 fonti
FDA committee recommends looser restrictions for several peptides
An FDA committee is recommending the addition of several peptides to the 503A bulk drug substances list.The FDA’s Pharmacy Compounding Advisory Committee, which has faced scrutiny for having several members with conflicts of interest, met July 23 and 24 to discuss peptides.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
forbes.com
FDA’s Review Of Peptides Signals A Growing Public Health Challenge
A FDA advisory committee will review evidence surrounding peptides. Experts are concerned there is a paucity of evidence to back their approval for legal compounding.
- ·
FDA Set To Review Safety And Access To Peptides: What You Need To Know
An FDA panel is reviewing seven peptides for potential approval, sparking concerns about their widespread use in compounding pharmacies and the gray market.
